Skip to main content

Table 2 DVH-parameters for PTV, heart and lungs represented as mean dose ± standard deviation

From: Clinical evaluation of two AI models for automated breast cancer plan generation

 

PTV

Lungs

Heart

Average dose [Gy]

Difference w.r.t. prescribed dose [%]

D2% [Gy]

MLD [Gy]

V5Gy [cm3]

MHD [Gy]

Clinical

40.07 ± 0.40

+ 0.1

41.69 ± 0.57

1.92 ± 0.62

325 ± 85

1.17 ± 0.77

cARF

40.37 ± 0.35*

+ 0.8

42.01 ± 0.56*

1.98 ± 0.64*

333 ± 87*

1.23 ± 0.76*

U-net

40.53 ± 0.36*

+ 1.2

42.02 ± 0.56*

1.96 ± 0.64

331 ± 86

1.24 ± 0.87*

  1. Asterisks indicate significant differences with the manual dose distribution (p ≤ 0.05)